News + Press

Explore by Category
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
May 09, 2023

PHILADELPHIA, May 9, 2023 /PRNewswire/ — Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for…

read more
Interius BioTherapeutics Announces Successful Manufacturing Partnership with WuXi Advanced Therapies
May 09, 2023

PHILADELPHIA, May 9, 2023 /PRNewswire/ — Interius BioTherapeutics, a preclinical stage gene therapy company developing novel methods for…

read more
Interius BioTherapeutics Hosts Immersive, Hands-on Event to Ignite Students’ Passion for Science
April 27, 2023

Philadelphia, PA – April 27, 2023 – Interius BioTherapeutics, a preclinical stage gene therapy company…

read more
Interius’ Senior Director of Analytical Development to Speak at 14th Annual Bioprocessing Summit
November 01, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
The BrightEdge Fund 2021 Annual Review
November 01, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
Interius Named as Finalist for the Deal of the Year Award by Life Sciences Pennsylvania
November 01, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
BioCentury’s 2021 Class of Emerging Companies
February 14, 2022

An innovation showcase of protein degraders, RNA therapeutics, delivery vectors and gene modifiers

read more
Interius Bio Announces Granting of US Patent to Support in Vivo Cell-Specific Gene Delivery Platform
December 09, 2021

Company also celebrates “Deal of the Year” awarded by The Penn Center for Innovation PHILADELPHIA,…

read more
Pennovation Lab Welcomes New Tenant Interius BioTherapeutics to Its Innovation Ecosystem
October 05, 2021
read more
Interius Design: Penn Spinout Gets Specific with In Vivo CAR Ts
June 03, 2021
read more
Interius Biotherapeutics Nabs $76M Series A
May 18, 2021
read more